{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:47:46Z","timestamp":1792896466854,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82300017"],"award-info":[{"award-number":["82300017"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jconrel.2026.114810","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:45:04Z","timestamp":1773161104000},"page":"114810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["M2 macrophage-mediated tigecycline nanoparticles for combating CRKP pneumonia via antibacterial and immunomodulatory therapy"],"prefix":"10.1016","volume":"393","author":[{"given":"Weijing","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2026.114810_bb0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01672-2023","article-title":"World pneumonia day 2023: the rising global threat of pneumonia and what we must do about it","volume":"62","author":"Cilloniz","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0010","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","article-title":"Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis","volume":"7","author":"McAllister","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2026.114810_bb0015","first-page":"27","article-title":"Epidemiology and resistance pattern in microbial pneumonia: a review: epidemiology and resistance pattern in microbial pneumonia","author":"Adil","year":"2022","journal-title":"Pak. J. Health Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114810_bb0020","first-page":"e108","article-title":"Clinical management of infections caused by carbapenem-resistant <em>Klebsiella pneumoniae<\/em> in critically ill patients: a nationwide survey of tertiary hospitals in mainland China","volume":"84","author":"Zha","year":"2022","journal-title":"J. Inf. Secur."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114810_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis","volume":"11","author":"Lin","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.014","article-title":"A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections","volume":"55","author":"Agyeman","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114810_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1165\/rcmb.F278","article-title":"Oxidative stress and acute lung injury","volume":"29","author":"Chow","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.114810_bb0040","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3389\/fimmu.2020.01722","article-title":"Pulmonary innate immune response determines the outcome of inflammation during pneumonia and Sepsis-associated acute lung injury","volume":"11","author":"Kumar","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114810_bb0045","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/AAC.01499-05","article-title":"Functional, biophysical, and structural bases for antibacterial activity of tigecycline","volume":"50","author":"Olson","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2026.114810_bb0050","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S0924-8579(09)70005-6","article-title":"A review of tigecycline \u2014 the first glycylcycline","volume":"32","author":"Peterson","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114810_bb0055","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review","volume":"41","author":"Yaghoubi","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114810_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijantimicag.2012.09.005","article-title":"The emergence of clinical resistance to tigecycline","volume":"41","author":"Sun","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114810_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02448-17","article-title":"Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection","volume":"9","author":"Band","year":"2018","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114810_bb0070","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/jac\/dkac240","article-title":"Understanding the suitability of established antibiotics for oral inhalation from a pharmacokinetic perspective: an integrated model-based investigation based on rifampicin, ciprofloxacin and tigecycline in vivo data","volume":"77","author":"Himstedt","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2026.114810_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117153","article-title":"Hydroxyl-based acid-hypersensitive acetal ester bond: design, synthesis and the application potential in nanodrugs","volume":"283","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114810_bb0080","first-page":"47","article-title":"Formulation of pH-responsive PEGylated nanoparticles with high drug loading capacity and programmable drug release for enhanced antibacterial activity","volume":"16","author":"Li","year":"2022","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114810_bb0085","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jbm.b.33635","article-title":"Skin and muscle permeating antibacterial nanoparticles for treating Staphylococcus aureus infected wounds","volume":"104","author":"Dhanalakshmi","year":"2016","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"45","key":"10.1016\/j.jconrel.2026.114810_bb0090","doi-asserted-by":"crossref","first-page":"20946","DOI":"10.1039\/C8NR07146B","article-title":"Design of smart targeted and responsive drug delivery systems with enhanced antibacterial properties","volume":"10","author":"Chen","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.114810_bb0095","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/IJN.S298159","article-title":"Recent advances in macrophage-mediated drug delivery systems","volume":"16","author":"Liang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114810_bb0100","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.2147\/IJN.S430877","article-title":"Advancements in macrophage-targeted drug delivery for effective disease management","volume":"18","author":"Liu","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114810_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118360","article-title":"Nanomaterial-driven macrophage polarization: emerging strategies for immunomodulation and regenerative medicine","volume":"190","author":"Dahri","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.114810_bb0110","article-title":"Macrophage polarization: an important role in inflammatory diseases","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114810_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115204","article-title":"Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders","volume":"207","author":"Zaid","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114810_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103339","article-title":"Resolving macrophage polarization through distinct Ca(2+) entry channel that maintains intracellular signaling and mitochondrial bioenergetics","volume":"24","author":"Nascimento Da Conceicao","year":"2021","journal-title":"iScience"},{"issue":"25","key":"10.1016\/j.jconrel.2026.114810_bb0125","doi-asserted-by":"crossref","first-page":"17937","DOI":"10.18632\/oncotarget.24788","article-title":"Phytochemicals as modulators of M1-M2 macrophages in inflammation","volume":"9","author":"Saqib","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.114810_bb0130","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10856-009-3854-6","article-title":"A novel nano drug delivery system based on tigecycline-loaded calciumphosphate coated with poly-DL-lactide-co-glycolide","volume":"21","author":"Ignjatovi\u0107","year":"2010","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-024-02373-z","article-title":"Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii","volume":"22","author":"Lan","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114810_bb0145","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C9RA10857B","article-title":"PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters","volume":"10","author":"Hern\u00e1ndez-Giottonini","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2026.114810_bb0150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74690","article-title":"Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses","volume":"11","author":"Lundahl","year":"2022","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114810_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030243","article-title":"A novel bivalent mannosylated targeting ligand displayed on nanoparticles selectively targets anti-inflammatory M2 macrophages","volume":"12","author":"Chen","year":"2020","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114810_bb0160","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/AEM.02750-06","article-title":"Assessment and interpretation of bacterial viability by using the LIVE\/DEAD BacLight kit in combination with flow cytometry","volume":"73","author":"Berney","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114810_bb0165","article-title":"Eugenol eliminates carbapenem-resistant Klebsiella pneumoniae via reactive oxygen species mechanism","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114810_bb0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections","volume":"2014","author":"Cardiff","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114810_bb0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114810_bb0180","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114810_bb0185","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.sjbs.2020.01.025","article-title":"Immunohistochemistry of IL-1\u03b2, IL-6 and TNF-\u03b1 in spleens of mice treated with gold nanoparticles","volume":"27","author":"Khan","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.114810_bb0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","article-title":"Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options","volume":"10","author":"Sheu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114810_bb0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/IJGM.S214305","article-title":"Carbapenem-resistant Klebsiella pneumoniae: microbiology key points for clinical practice","volume":"12","author":"Reyes","year":"2019","journal-title":"Int. J. Gen. Med."},{"issue":"32","key":"10.1016\/j.jconrel.2026.114810_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202401549","article-title":"An all-in-one nano-biomimetic polyamidoamine dendrimer platform for treatment of CRKP pneumonia","volume":"34","author":"Duan","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-024-02093-8","article-title":"A pan-immune panorama of bacterial pneumonia revealed by a large-scale single-cell transcriptome atlas","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114810_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175140","article-title":"Tigecycline resistance among carbapenem-resistant klebsiella pneumoniae: clinical characteristics and expression levels of efflux pump genes","volume":"12","author":"Chiu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114810_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jgar.2021.04.006","article-title":"Dose optimisation based on pharmacokinetic\/pharmacodynamic target of tigecycline","volume":"25","author":"Leng","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114810_bb0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00011-020-01378-2","article-title":"Macrophage polarization and its role in the pathogenesis of acute lung injury\/acute respiratory distress syndrome","volume":"69","author":"Chen","year":"2020","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114810_bb0225","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00939-16","article-title":"Differential macrophage polarization from pneumocystis in immunocompetent and immunosuppressed hosts: potential adjunctive therapy during pneumonia","volume":"85","author":"Nandakumar","year":"2017","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114810_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020436","article-title":"Macrophages in lung injury, repair, and fibrosis","volume":"10","author":"Cheng","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114810_bb0235","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.apsb.2025.08.012","article-title":"Ferrum@albumin assembled nanoclusters inhibit NF-\u03baB signaling pathway for NIR enhanced acute lung injury immunotherapy","volume":"15","author":"Guan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"14","key":"10.1016\/j.jconrel.2026.114810_bb0240","article-title":"Reprogramming lung redox homeostasis by NIR driven ultra-small pd loaded covalent organic framework inhibits NF-\u03baB pathway for acute lung injury immunotherapy","volume":"12","author":"Lei","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.114810_bb0245","first-page":"0096","article-title":"Inflammation and microbiota regulation potentiate pneumonia therapy by biomimetic bacteria and macrophage membrane nanosystem","volume":"6","author":"Li","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114810_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/smmd.70021","article-title":"Ultrasound-responsive microcapsules delivering oxygen and traditional Chinese medicine for wound healing","volume":"4","author":"Wen","year":"2025","journal-title":"Smart Med."},{"key":"10.1016\/j.jconrel.2026.114810_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217772","article-title":"Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies","volume":"625","author":"Bai","year":"2025","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.jconrel.2026.114810_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411901","article-title":"Intracellular calcium as a regulator of polarization and target reprogramming of macrophages","volume":"26","author":"Pogonyalova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0265","article-title":"Calhm6 governs macrophage polarization through Chp1-Camk4-Creb1 Axis and Ectosomal delivery in inflammatory responses","volume":"13","author":"Xin","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114810_bb0270","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbalip.2006.08.003","article-title":"Control of phospholipase A2 activities for the treatment of inflammatory conditions","volume":"1761","author":"Yedgar","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114810_bb0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.1402830","article-title":"Dual-specificity phosphatase 1 and Tristetraprolin cooperate to regulate macrophage responses to lipopolysaccharide","volume":"195","author":"Smallie","year":"2015","journal-title":"J. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:05:38Z","timestamp":1781715938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"alternative-id":["S0168365926002129"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114810","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M2 macrophage-mediated tigecycline nanoparticles for combating CRKP pneumonia via antibacterial and immunomodulatory therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114810"}}